vs
Bank First Corp（BFC）与RHYTHM PHARMACEUTICALS, INC.（RYTM）财务数据对比。点击上方公司名可切换其他公司
RHYTHM PHARMACEUTICALS, INC.的季度营收约是Bank First Corp的1.3倍（$60.1M vs $44.9M），Bank First Corp净利率更高（45.8% vs -92.6%，领先138.3%），RHYTHM PHARMACEUTICALS, INC.同比增速更快（83.8% vs 12.1%），过去两年RHYTHM PHARMACEUTICALS, INC.的营收复合增速更高（43.8% vs 9.1%）
First Horizon Corporation（前身为田纳西第一银行）是一家成立于1864年、总部位于美国田纳西州孟菲斯的金融服务企业。通过旗下子公司First Horizon银行，其业务覆盖美国东南部12个州，是该区域第四大区域性银行。
Rhythm Pharmaceuticals是一家专注于罕见病领域的生物制药企业，主要开发和商业化针对罕见遗传性肥胖症的靶向疗法，覆盖POMC缺陷、LEPR缺陷、巴德-毕德氏综合征等适应症，服务北美、欧洲地区缺少有效治疗方案的患者群体。
BFC vs RYTM — 直观对比
营收规模更大
RYTM
是对方的1.3倍
$44.9M
营收增速更快
RYTM
高出71.7%
12.1%
净利率更高
BFC
高出138.3%
-92.6%
两年增速更快
RYTM
近两年复合增速
9.1%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $44.9M | $60.1M |
| 净利润 | $18.4M | $-55.6M |
| 毛利率 | — | 88.1% |
| 营业利润率 | 51.0% | -87.1% |
| 净利率 | 45.8% | -92.6% |
| 营收同比 | 12.1% | 83.8% |
| 净利润同比 | 4.8% | — |
| 每股收益（稀释后） | $1.87 | $-0.83 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BFCRYTM
| Q1 26 | — | $60.1M | ||
| Q4 25 | $44.9M | $57.3M | ||
| Q3 25 | $44.2M | $51.3M | ||
| Q2 25 | $41.6M | $48.5M | ||
| Q1 25 | $43.1M | $32.7M | ||
| Q4 24 | $40.1M | $41.8M | ||
| Q3 24 | $40.8M | $33.3M | ||
| Q2 24 | $38.9M | $29.1M |
净利润BFCRYTM
| Q1 26 | — | $-55.6M | ||
| Q4 25 | $18.4M | $-47.5M | ||
| Q3 25 | $18.0M | $-52.9M | ||
| Q2 25 | $16.9M | $-46.6M | ||
| Q1 25 | $18.2M | $-49.5M | ||
| Q4 24 | $17.5M | $-43.3M | ||
| Q3 24 | $16.6M | $-43.6M | ||
| Q2 24 | $16.1M | $-32.3M |
毛利率BFCRYTM
| Q1 26 | — | 88.1% | ||
| Q4 25 | — | 91.6% | ||
| Q3 25 | — | 89.3% | ||
| Q2 25 | — | 88.6% | ||
| Q1 25 | — | 88.8% | ||
| Q4 24 | — | 90.9% | ||
| Q3 24 | — | 88.5% | ||
| Q2 24 | — | 89.9% |
营业利润率BFCRYTM
| Q1 26 | — | -87.1% | ||
| Q4 25 | 51.0% | -82.2% | ||
| Q3 25 | 50.8% | -102.6% | ||
| Q2 25 | 49.7% | -93.4% | ||
| Q1 25 | 51.3% | -143.7% | ||
| Q4 24 | 54.4% | -98.6% | ||
| Q3 24 | 50.7% | -132.0% | ||
| Q2 24 | 51.0% | -139.2% |
净利率BFCRYTM
| Q1 26 | — | -92.6% | ||
| Q4 25 | 45.8% | -83.0% | ||
| Q3 25 | 40.7% | -103.1% | ||
| Q2 25 | 40.5% | -96.1% | ||
| Q1 25 | 42.3% | -151.4% | ||
| Q4 24 | 49.3% | -103.6% | ||
| Q3 24 | 40.6% | -131.2% | ||
| Q2 24 | 41.3% | -110.9% |
每股收益（稀释后）BFCRYTM
| Q1 26 | — | $-0.83 | ||
| Q4 25 | $1.87 | $-0.73 | ||
| Q3 25 | $1.83 | $-0.82 | ||
| Q2 25 | $1.71 | $-0.75 | ||
| Q1 25 | $1.82 | $-0.81 | ||
| Q4 24 | $1.75 | $-0.71 | ||
| Q3 24 | $1.65 | $-0.73 | ||
| Q2 24 | $1.59 | $-0.55 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $243.2M | $340.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $643.8M | $122.9M |
| 总资产 | $4.5B | $442.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资BFCRYTM
| Q1 26 | — | $340.6M | ||
| Q4 25 | $243.2M | $388.9M | ||
| Q3 25 | $126.2M | $416.1M | ||
| Q2 25 | $120.3M | $291.0M | ||
| Q1 25 | $300.9M | $314.5M | ||
| Q4 24 | $261.3M | $320.6M | ||
| Q3 24 | $204.4M | $298.4M | ||
| Q2 24 | $99.0M | $319.1M |
股东权益BFCRYTM
| Q1 26 | — | $122.9M | ||
| Q4 25 | $643.8M | $139.1M | ||
| Q3 25 | $628.1M | $148.8M | ||
| Q2 25 | $612.3M | $-11.9M | ||
| Q1 25 | $648.4M | $18.9M | ||
| Q4 24 | $639.7M | $21.7M | ||
| Q3 24 | $628.9M | $11.2M | ||
| Q2 24 | $614.6M | $39.3M |
总资产BFCRYTM
| Q1 26 | — | $442.3M | ||
| Q4 25 | $4.5B | $480.2M | ||
| Q3 25 | $4.4B | $506.9M | ||
| Q2 25 | $4.4B | $372.7M | ||
| Q1 25 | $4.5B | $386.7M | ||
| Q4 24 | $4.5B | $392.3M | ||
| Q3 24 | $4.3B | $363.6M | ||
| Q2 24 | $4.1B | $381.8M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $62.5M | — |
| 自由现金流经营现金流 - 资本支出 | $51.0M | — |
| 自由现金流率自由现金流/营收 | 113.6% | — |
| 资本支出强度资本支出/营收 | 25.5% | — |
| 现金转化率经营现金流/净利润 | 3.40× | — |
| 过去12个月自由现金流最近4个季度 | $75.8M | — |
8季度趋势，按日历期对齐
经营现金流BFCRYTM
| Q1 26 | — | — | ||
| Q4 25 | $62.5M | $-25.4M | ||
| Q3 25 | $15.5M | $-26.6M | ||
| Q2 25 | $11.9M | $-23.3M | ||
| Q1 25 | $6.2M | $-40.4M | ||
| Q4 24 | $65.8M | $-18.8M | ||
| Q3 24 | $18.8M | $-25.2M | ||
| Q2 24 | $14.9M | $-29.1M |
自由现金流BFCRYTM
| Q1 26 | — | — | ||
| Q4 25 | $51.0M | — | ||
| Q3 25 | $12.5M | — | ||
| Q2 25 | $8.2M | — | ||
| Q1 25 | $4.0M | — | ||
| Q4 24 | $58.6M | — | ||
| Q3 24 | $16.9M | — | ||
| Q2 24 | $13.7M | — |
自由现金流率BFCRYTM
| Q1 26 | — | — | ||
| Q4 25 | 113.6% | — | ||
| Q3 25 | 28.2% | — | ||
| Q2 25 | 19.8% | — | ||
| Q1 25 | 9.3% | — | ||
| Q4 24 | 146.3% | — | ||
| Q3 24 | 41.5% | — | ||
| Q2 24 | 35.3% | — |
资本支出强度BFCRYTM
| Q1 26 | — | — | ||
| Q4 25 | 25.5% | — | ||
| Q3 25 | 6.7% | — | ||
| Q2 25 | 8.7% | — | ||
| Q1 25 | 5.0% | — | ||
| Q4 24 | 18.0% | — | ||
| Q3 24 | 4.5% | — | ||
| Q2 24 | 3.1% | — |
现金转化率BFCRYTM
| Q1 26 | — | — | ||
| Q4 25 | 3.40× | — | ||
| Q3 25 | 0.86× | — | ||
| Q2 25 | 0.70× | — | ||
| Q1 25 | 0.34× | — | ||
| Q4 24 | 3.75× | — | ||
| Q3 24 | 1.13× | — | ||
| Q2 24 | 0.93× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
